The expanded access program (EAP) is available to eligible patients with erythropoietic protoporphyria (EPP) and provides access to bitopertin ...

Brain tissue oxygenation in early stage of stroke with BXT-25 is monitored in real time . BOSTON, MASSACHUSETTS, May 29, 2026 (GLOBE NEWSWIRE) -- Bioxytran Inc. (OTCQB: BIXT), a b ...

Iron-deficiency anemia leaves roughly one in three women of reproductive age worldwide feeling chronically exhausted, short of breath, and unable to concentrate. Standard treatment is simple: daily ...

Tea and coffee may interfere with iron and mineral absorption, making supplement timing important for nutrient effectiveness.

Vitamins C, A, and B, as well as the amino acid l-lysine, are supplements that can be taken with iron to improve energy and reduce tiredness and fatigue. These supplements raise blood iron levels, ...

Brendan McGuire, MD, discusses hallmark clinical features of the rare disease, acute hepatic porphyria, diagnostic delays, unnecessary operations, and more. Dr Sherman: Hi everybody, I’m Dr Gregg ...

Completed enrollment of the Phase 3 APOLLO study of bitopertin in erythropoietic protoporphyria (EPP); topline data expected in Q4 2026Updated ...

Heme, an iron–protoporphyrin IX complex, is synthesised through an eight-step pathway beginning and ending in the mitochondrial matrix, with several cytosolic intermediates. Ferrochelatase catalyses ...

Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed. For years, mitochondrial dysfunction has been recognized as a hallmark of exhausted T cells in tumors. Yet ...

Acute hepatic porphyria (AHP) is a group of rare genetic disorders that affect the liver’s ability to produce heme, a vital component of blood, and can manifest with a variety of symptoms often ...

Acute Hepatic Porphyria (AHP) is a group of rare genetic liver disorders that can cause severe, life threatening attacks and long-term health issues that require monitoring. Treatment for AHP focuses ...

ABSTRACT: Background: Bilirubin is the metabolic end-product of heme degradation by heme oxy-genase (HO), which has recently been shown to act as an antioxidant which can protect against ...